Obstetrics & Gynecology Doctors in Jasper, AL Accepting Medicare

6 Obstetrics & Gynecology doctors found. Showing 1 - 6

Dr. Oscar Domingo Almeida Jr., M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1800 Birmingham Ave, Jasper, AL 35501 Phone: 205-384-4585    Fax: 205-384-4428

Talia Gates, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 304 Blackwell Dairy Rd, Jasper, AL 35504 Phone: 205-384-4801    Fax: 205-384-4538

Dr. Garrison Stephen Cowen, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 701 East 19th Street, Jasper, AL 35501 Phone: 205-221-1516

Dr. Roy Lee Sims, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 3400 Highway 78 E, Suite 316 Medical Arts Tower, Jasper, AL 35501 Phone: 205-221-7301    Fax: 205-221-7394

Bridget Suzanne Brunner, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 304 Blackwell Dairy Rd, Jasper, AL 35504 Phone: 205-384-4801

Ms. Lorissia Renea Autery, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 304 Blackwell Dairy Rd, Jasper, AL 35504 Phone: 205-384-4801    Fax: 205-384-4538

News Archive

Day-tripping to the dispensary: Seniors in pain hop aboard the canna-bus

Shirley Avedon, 90,­­ had never been a cannabis user. But carpal tunnel syndrome that sends shooting pains into both of her hands and an aversion to conventional steroid and surgical treatments is prompting her to consider some new options.

Semafore's SF1126 peptidic prodrug demonstrates clinical activity in chronic lymphocytic leukemia

Semafore Pharmaceuticals today announced the presentation of preliminary clinical data demonstrating that SF1126 has clinical activity in chronic lymphocytic leukemia (CLL). SF1126 is a novel peptidic prodrug that converts to LY294002, one of the most widely studied small molecule inhibitors of both phosphatidylinositol 3-kinase (PI3K) and mammalian target of rapamycin (mTOR). The results were presented at Cambridge Healthtech Institute's 8th Annual Next-Gen Kinase Inhibitors Oncology & Beyond Conference being held June 21-23, 2010, in Cambridge, Massachusetts.

How exactly does aging affect judgment and decision-making abilities?

We often read or hear stories about older adults being conned out of their life savings, but are older individuals really more susceptible to fraud than younger adults?

Researchers report results from Phase III DEFINE study for coronary heart disease

Researchers today presented results from the Phase III DEFINE (Determining the EFficacy and Tolerability of CETP INhibition with AnacEtrapib) study with Merck's investigational CETP inhibitor, anacetrapib. In the trial of 1,623 patients with coronary heart disease (CHD) or CHD risk equivalents, anacetrapib showed no significant differences from placebo in the primary safety measures studied.

UMMC to partner with Mayo Clinic to discover new therapies, train new medical scientists

The University of Mississippi Medical Center will partner with the renowned Mayo Clinic on a series of initiatives intended to convert laboratory discoveries into new therapies and train a new generation of medical scientists.

Read more Medical News

› Verified 1 days ago